3rd Quarter - Report

SIDLEY AUSTIN LLP for VIFOR PHARMA LTD

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitoring and analyzing Medicare policy for in stage renal disease

LobbyistCovered position, as disclosed
PATRICIA LOUISE DELOATCHE Health Policy Director; Sen. Orrin Hatch; Chief of Staff, Legislative Director and Legislative Assistant for Rep. Mike Bilirakis

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)

LobbyistCovered position, as disclosed
PATRICIA LOUISE DELOATCHE Health Policy Director; Sen. Orrin Hatch; Chief of Staff, Legislative Director and Legislative Assistant for Rep. Mike Bilirakis
DORA HUGHES New Deputy Director of Health, HELP, Sen. Edward Kennedy; Health Policy Advisor, Sen. Barack Obama; Counselor for Science and Public Health, HHS

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1576 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.